{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:20:06Z","timestamp":1782951606146,"version":"3.54.5"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.rdc.2021.07.011","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T20:58:22Z","timestamp":1637096302000},"page":"371-395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Systemic Autoinflammatory Diseases"],"prefix":"10.1016","volume":"48","author":[{"given":"Maria J.","family":"Gutierrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivia K.","family":"Lapidus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2021.07.011_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-23-1-1","article-title":"Benign paroxysmal peritonitis","volume":"23","author":"Siegal","year":"1945","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.rdc.2021.07.011_bib2","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2017-212515","article-title":"Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study","volume":"77","author":"Ben-Chetrit","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.011_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.011_bib4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.3777","article-title":"The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation","volume":"18","author":"Manthiram","year":"2017","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.011_bib5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s12016-017-8613-8","article-title":"Geoepidemiology and immunologic features of autoinflammatory diseases: a comprehensive review","volume":"54","author":"Jamilloux","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.011_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jaci.2014.07.050","article-title":"Myeloid lineage\u2013restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome","volume":"135","author":"de Koning","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"27","key":"10.1016\/j.rdc.2021.07.011_bib7","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.011_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1651-2227.2009.01554.x","article-title":"A\u00a0clinical review of 105 patients with PFAPA (a periodic fever syndrome)","volume":"99","author":"Feder","year":"2010","journal-title":"Acta Paediatr"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.011_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.011_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jclinpath-2017-204698","article-title":"SIFD as a novel cause of severe fetal hydrops and neonatal anaemia with iron loading and marked extramedullary haemopoiesis","volume":"71","author":"Barton","year":"2018","journal-title":"J\u00a0Clin Pathol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.011_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clim.2012.08.003","article-title":"A\u00a0novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset","volume":"145","author":"Altiok","year":"2012","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.011_bib12","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809324","article-title":"OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death","volume":"11","author":"Damgaard","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.011_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.ejhg.5200658","article-title":"The spectrum of Familial Mediterranean Fever (FMF) mutations","volume":"9","author":"Touitou","year":"2001","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.011_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.pcl.2018.04.005","article-title":"Systemic juvenile idiopathic arthritis","volume":"65","author":"Lee","year":"2018","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.rdc.2021.07.011_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8562485","article-title":"Clinical features at onset and genetic characterization of pediatric and adult patients with TNF- \u03b1 Receptor\u2014Associated Periodic Syndrome (TRAPS): A series of 80 cases from the AIDA Network","volume":"2020","author":"Gaggiano","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.rdc.2021.07.011_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00318","article-title":"Genetic and epigenetic determinants in autoinflammatory diseases","volume":"8","author":"\u00c1lvarez-Errico","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.011_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.011_bib18","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keu437","article-title":"Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes","volume":"54","author":"Ros\u00e9","year":"2015","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.011_bib19","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/art.40147","article-title":"Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood: DADA2 in patients with antibody deficiency","volume":"69","author":"Schepp","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.011_bib20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.humpath.2015.02.010","article-title":"Loss of ADAM17 is associated with severe multiorgan dysfunction","volume":"46","author":"Bandsma","year":"2015","journal-title":"Hum Pathol"},{"issue":"7788","key":"10.1016\/j.rdc.2021.07.011_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-019-1828-5","article-title":"Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease","volume":"577","author":"Lalaoui","year":"2020","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.rdc.2021.07.011_bib22","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.2457","article-title":"Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency","volume":"13","author":"Boisson","year":"2012","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.011_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.20141130","article-title":"Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia","volume":"212","author":"Boisson","year":"2015","journal-title":"J\u00a0Exp Med"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.011_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.011_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archdermatol.2011.3014","article-title":"DIRA, DITRA, and new insights into pathways of skin inflammation: what\u2019s in a name?","volume":"148","author":"Cowen","year":"2012","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.rdc.2021.07.011_bib26","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1007\/s00296-011-2180-8","article-title":"Incidence and clinical features of hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) and spectrum of mevalonate kinase (MVK) mutations in German children","volume":"32","author":"Lainka","year":"2012","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.011_bib27","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","article-title":"A\u00a0new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.011_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20161228","article-title":"Autoinflammatory periodic fever, immunodeficiency, and thrombocytopenia (PFIT) caused by mutation in actin-regulatory gene WDR1","volume":"214","author":"Standing","year":"2017","journal-title":"J\u00a0Exp Med"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.011_bib29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00296-019-04259-y","article-title":"The right place of interleukin-1 inhibitors in the treatment of Beh\u00e7et\u2019s syndrome: a systematic review","volume":"39","author":"Bettiol","year":"2019","journal-title":"Rheumatol Int"},{"issue":"10","key":"10.1016\/j.rdc.2021.07.011_bib30","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"issue":"13","key":"10.1016\/j.rdc.2021.07.011_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21134788","article-title":"The NLRP1 inflammasome in human skin and beyond","volume":"21","author":"Fenini","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.rdc.2021.07.011_bib32","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00109-016-1465-5","article-title":"Insights from mendelian interferonopathies: comparison of CANDLE, SAVI with AGS, monogenic lupus","volume":"94","author":"Kim","year":"2016","journal-title":"J\u00a0Mol Med"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.011_bib33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ng.2933","article-title":"Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling","volume":"46","author":"Rice","year":"2014","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.011_bib34","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI129301","article-title":"Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases","volume":"130","author":"de Jesus","year":"2020","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.011_bib35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1312625","article-title":"Activated STING in a vascular and pulmonary syndrome","volume":"371","author":"Liu","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.011_bib36","doi-asserted-by":"crossref","first-page":"e20192319","DOI":"10.1084\/jem.20192319","article-title":"Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy","volume":"217","author":"Gruber","year":"2020","journal-title":"J\u00a0Exp Med"},{"issue":"42","key":"10.1016\/j.rdc.2021.07.011_bib37","doi-asserted-by":"crossref","first-page":"eaav7501","DOI":"10.1126\/sciimmunol.aav7501","article-title":"Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2","volume":"4","author":"Duncan","year":"2019","journal-title":"Sci Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.011_bib38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/ni.3420","article-title":"A\u00a0human inborn error connects the \u03b1\u2019s","volume":"17","author":"Meyts","year":"2016","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.011_bib39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni.3409","article-title":"DNA polymerase-\u03b1 regulates the activation of type I interferons through cytosolic RNA:DNA synthesis","volume":"17","author":"Starokadomskyy","year":"2016","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.011_bib40","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/s41467-020-18925-4","article-title":"Early-onset autoimmunity associated with SOCS1 haploinsufficiency","volume":"11","author":"Hadjadj","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.rdc.2021.07.011_bib41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3389\/fimmu.2017.00927","article-title":"CANDLE syndrome as a paradigm of proteasome-related autoinflammation","volume":"8","author":"Torrelo","year":"2017","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.011_bib42","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1172\/JCI86020","article-title":"Additive loss-of-function proteasome subunit mutations in CANDLE\/PRAAS patients promote type 1 IFN production","volume":"126","author":"Brehm","year":"2016","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.011_bib43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ajhg.2018.01.019","article-title":"Heterozygous mutations in OAS1 cause infantile-onset pulmonary alveolar proteinosis with hypogammaglobulinemia","volume":"102","author":"Cho","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.011_bib44","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1034\/j.1399-0004.2003.00033.x","article-title":"A\u00a0novel syndrome of combined immunodeficiency, autoimmunity and spondylometaphyseal dysplasia: a novel syndrome of combined immunodeficiency, autoimmunity and spondylometaphyseal dysplasia","volume":"63","author":"Roifman","year":"2003","journal-title":"Clin Genet"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.011_bib45","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jaci.2019.06.003","article-title":"Gain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy","volume":"144","author":"G\u00f6\u00f6s","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.rdc.2021.07.011_bib46","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.011_bib47","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1084\/jem.20160724","article-title":"Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration","volume":"214","author":"Badran","year":"2017","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.011_bib48","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jaci.2019.06.017","article-title":"Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1\u03b2 inhibition","volume":"144","author":"Gernez","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.011_bib49","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.jaci.2019.02.003","article-title":"A\u00a0combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency","volume":"143","author":"Volpi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.rdc.2021.07.011_bib50","doi-asserted-by":"crossref","first-page":"e20192275","DOI":"10.1084\/jem.20192275","article-title":"NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammation","volume":"217","author":"Castro","year":"2020","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.011_bib51","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.011_bib52","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajhg.2012.08.006","article-title":"A\u00a0hypermorphic missense mutation in PLCG2, encoding phospholipase C\u03b32, causes a dominantly inherited autoinflammatory disease with immunodeficiency","volume":"91","author":"Zhou","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.011_bib53","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ng.3279","article-title":"COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis","volume":"47","author":"Watkin","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.011_bib54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12663-010-0164-y","article-title":"Cherubism: case report with review of literature","volume":"10","author":"Mehrotra","year":"2011","journal-title":"J\u00a0Maxillofac Oral Surg"},{"key":"10.1016\/j.rdc.2021.07.011_bib55","doi-asserted-by":"crossref","unstructured":"Satveer M, Twelves S, Farkas K, et al. AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 Production. J Invest Dermatology 2016; 136(11) 2251-2259.","DOI":"10.1016\/j.jid.2016.06.618"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.011_bib56","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1038\/s41598-019-40874-2","article-title":"Biallelic loss-of-function LACC1\/FAMIN Mutations Presenting as Rheumatoid Factor-Negative Polyarticular Juvenile Idiopathic Arthritis","volume":"9","author":"Rabionet","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.011_bib57","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.011_bib58","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaci.2020.09.016","article-title":"Highways to hell: mechanism-based management of cytokine storm syndromes","volume":"146","author":"Canna","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10170","key":"10.1016\/j.rdc.2021.07.011_bib59","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0140-6736(18)32763-6","article-title":"Baricitinib for systemic lupus erythematosus","volume":"393","author":"Yuan","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.011_bib60","doi-asserted-by":"crossref","first-page":"171","DOI":"10.12788\/j.sder.2015.0170","article-title":"Differential diagnosis and management of oral ulcers","volume":"34","author":"Siu","year":"2015","journal-title":"Semin Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.011_bib61","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaip.2018.05.006","article-title":"Mimickers of urticaria: urticarial vasculitis and autoinflammatory diseases","volume":"6","author":"Davis","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6404","key":"10.1016\/j.rdc.2021.07.011_bib62","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.aar2641","article-title":"Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation","volume":"361","author":"Cuchet-Louren\u00e7o","year":"2018","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.011_bib63","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.pcl.2005.02.007","article-title":"Distinguishing among prolonged, recurrent, and periodic fever syndromes: approach of a pediatric infectious diseases subspecialist","volume":"52","author":"Long","year":"2005","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.rdc.2021.07.011_bib64","series-title":"Textbook of autoinflammation","first-page":"203","article-title":"Clinical approach to the diagnosis of autoinflammatory diseases","author":"Hashkes","year":"2019"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.011_bib65","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1542\/neo.20-2-e67","article-title":"Primary immunodeficiency in the NICU","volume":"20","author":"O\u2019Connell","year":"2019","journal-title":"Neoreviews"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.011_bib66","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaci.2019.09.009","article-title":"Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: a working group report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma & Immunology","volume":"145","author":"Chinn","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.011_bib67","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/clinchem\/hvaa024","article-title":"ISSAID\/EMQN best practice guidelines for the genetic diagnosis of monogenic autoinflammatory diseases in the next-generation sequencing era","volume":"66","author":"Shinar","year":"2020","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.011_bib68","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jmedgenet-2017-105216","article-title":"New workflow for classification of genetic variants\u2019 pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID)","volume":"55","author":"Gijn","year":"2018","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.011_bib69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13023-017-0720-3","article-title":"A\u00a0web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry","volume":"12","author":"Papa","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"25","key":"10.1016\/j.rdc.2021.07.011_bib70","doi-asserted-by":"crossref","first-page":"14405","DOI":"10.1073\/pnas.2002051117","article-title":"Common genetic susceptibility loci link PFAPA syndrome, Beh\u00e7et\u2019s disease, and recurrent aphthous stomatitis","volume":"117","author":"Manthiram","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rdc.2021.07.011_bib71","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3389\/fimmu.2020.00865","article-title":"Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide","volume":"11","author":"Soriano","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.rdc.2021.07.011_bib72","doi-asserted-by":"crossref","first-page":"108697","DOI":"10.1016\/j.clim.2021.108697","article-title":"Undifferentiated recurrent fevers in pediatrics are clinically distinct from PFAPA syndrome but retain an IL-1 signature","volume":"226","author":"Luu","year":"2021","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.011_bib73","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.011_bib74","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jpeds.2012.05.047","article-title":"Colchicine is a safe drug in children with familial Mediterranean fever","volume":"161","author":"Padeh","year":"2012","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.011_bib75","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1651-2227.2009.01554.x","article-title":"A clinical review of 105 patients with PFAPA (a periodic fever syndrome)","volume":"99","author":"Feder","year":"2010","journal-title":"Acta P\u00e6diatrica"},{"key":"10.1016\/j.rdc.2021.07.011_bib76","first-page":"1","article-title":"Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis Syndrome: Relapse and Tonsillar Regrowth After Childhood Tonsillectomy","volume":"00","author":"Lantto","year":"2021","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.011_bib77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/0194599818807917","article-title":"Clinical Practice Guideline: Tonsillectomy in Children (Update)\u2014Executive Summary","volume":"160","author":"Mitchell","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"17","key":"10.1016\/j.rdc.2021.07.011_bib78","doi-asserted-by":"crossref","first-page":"7148","DOI":"10.1073\/pnas.1103681108","article-title":"Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade","volume":"108","author":"Stojnaov","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rdc.2021.07.011_bib79","unstructured":"Available at: https:\/\/www.fda.gov\/media\/124784\/download."},{"key":"10.1016\/j.rdc.2021.07.011_bib80","doi-asserted-by":"crossref","first-page":"568865","DOI":"10.3389\/fphar.2020.568865","article-title":"Long-term follow-up and optimization of interleukin-1 inhibitors in the management of monogenic autoinflammatory diseases: real-life data from the jir cohort","volume":"11","author":"Hentgen","year":"2021","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.011_bib81","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.011_bib82","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/acr.23120","article-title":"International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency\/Hyperimmunoglobulinemia D Syndrome","volume":"69","author":"Ozen","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.011_bib83","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.24294","article-title":"Proinflammatory action of the anti-inflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome","volume":"60","author":"Nedjai","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.011_bib84","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keu437","article-title":"Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes","volume":"54","author":"Ros\u00e9","year":"2015","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.rdc.2021.07.011_bib85","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/art.39763","article-title":"The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry","volume":"68","author":"Ter Haar","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.011_bib86","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/RHU.0b013e31823682f5","article-title":"Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and\/or sacroiliitis who were resistant to colchicine treatment","volume":"17","author":"Bilgen","year":"2011","journal-title":"J Clin Rheumato"},{"issue":"9","key":"10.1016\/j.rdc.2021.07.011_bib87","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/art.39699","article-title":"Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases","volume":"68","author":"Nanthapisal","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.011_bib88","first-page":"20","article-title":"A practical approach to monitoring patients on biological agents for the treatment of psoriasis","volume":"3","author":"Emer","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.011_bib89","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Montealegre Sanchez","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rdc.2021.07.011_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijporl.2019.02.047","article-title":"Vitamin D deficiency as a risk factor for PFAPA syndrome","volume":"121","author":"Nalbanto\u011flu","year":"2019","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.rdc.2021.07.011_bib91","first-page":"8","article-title":"Vitamin D levels in children with familial Mediterranean fever","volume":"35","author":"Onur","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2021.07.011_bib92","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3389\/fimmu.2019.02783","article-title":"Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination","volume":"10","author":"Zebing","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.rdc.2021.07.011_bib93","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12969-020-0409-3","article-title":"Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD\/HIDS: a German PRO-KIND initiative","volume":"18","author":"Hansmann","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.011_bib94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12969-020-00424-x","article-title":"Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the childhood arthritis and rheumatology research alliance (CARRA) PFAPA work group","volume":"18","author":"Amarilyo","year":"2020","journal-title":"Pediatr Rheumatol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X21011054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X21011054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:23:44Z","timestamp":1760181824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X21011054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0889857X21011054"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2021.07.011","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Autoinflammatory Diseases","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2021.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}